Skip to main content

Boao Biotech Ltd's Form 4 filing

Yubo International Biotech Ltd (YBGJ) · filed Jun 3, 2025

Accession no.
0001640334-25-000982
Filed
Jun 3, 2025, 3:23 PM ET
Trade date
Jan 25, 2024
Filing delay
495 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.51M. It was filed 495 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Boao Biotech LtdCIK 000184139910% Owner
Cao YulinCIK 000206735010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 25, 2024Class A Common StockSSaleDisposed−500,000$0.30−$150,00024,467,800Direct
Jan 25, 2024Class A Common StockSSaleDisposed−741,521$0.30−$222,456.323,726,279Direct
Jan 25, 2024Class A Common StockSSaleDisposed−301,701$0.30−$90,510.323,424,578Direct
Jan 25, 2024Class A Common StockSSaleDisposed−364,351$0.30−$109,305.323,060,227Direct
Jan 25, 2024Class A Common StockSSaleDisposed−181,256$0.30−$54,376.822,878,971Direct
Jan 25, 2024Class A Common StockSSaleDisposed−86,897$0.30−$26,069.122,792,074Direct
Jan 25, 2024Class A Common StockSSaleDisposed−426,654$0.30−$127,996.222,365,420Direct
Jan 25, 2024Class A Common StockSSaleDisposed−2,057,586$0.30−$617,275.820,307,834Direct
Jan 25, 2024Class A Common StockSSaleDisposed−380,174$0.30−$114,052.219,927,660Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)